TP53 and cancer: On the basis of the previously confirmed genetic defects in the human tumor cell lines analyzed, including mutations p53 [28], it is evident that the antineoplastic effect of ACCA, acting through MCT1, does not depend on the action of this tumor suppressor gene that is frequently altered in human cancers.